The aim of the company is to increase its geographical presence continually. Backed by its portfolio of formulations across a broad spectrum of therapeutic categories from prescription drugs to OTC products. We are making inroads in different geographies of the globe from non-regulated to semi regulated and regulated markets. We wish to expand our commercial foot print from 30 countries to 70 countries in next 5 years.